Improvement effect on endothelial function in patients with congestive heart failure treated with cardiac resynchronization therapy

Journal of Cardiology

Volumn 58, Issue 1, 2011, Pages 69-73

  Enomoto, Koji ^a   Yamabe, Hiroshige ^a   Toyama, Kensuke ^a   Matsuzawa, Yasushi ^a   Yamamuro, Megumi ^a   Uemura, Takashi ^a   Morihisa, Kenji ^a   Iwashita, Satomi ^a   Kaikita, Koichi ^a   Sugiyama, Seigo ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cardiac output; Cardiomyopathies; Dilated; Endothelium; Heart failure; Treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART OUTPUT; HUMAN; MALE; PROTEIN BLOOD LEVEL; REACTIVE HYPEREMIA PERIPHERAL ARTERIAL TONOMETRY; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TONOMETRY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

CARDIAC OUTPUT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY, DILATED; ENDOTHELIUM, VASCULAR; FEMALE; HEART FAILURE; HUMANS; MALE; MANOMETRY; MIDDLE AGED;

EID: 79959723257     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.01.010     Document Type: Article

References (20)

1. Katz S.D., Hryniewicz K., Hriljac I., Balidemaj K., Dimayuga C., Hudaihed A., Yasskiy A. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005, 111:310-314.
2. Meyer B., Mörtl D., Strecker K., Hülsmann M., Kulemann V., Neunteufl T., Pacher R., Berger R. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol 2005, 46:1011-1018.
3. Rivero-Ayerza M., Theuns D.A., Garcia-Garcia H.M., Boersma E., Simoons M., Jordaens L.J. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 2006, 27:2682-2688.
4. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Packer M., Clavell A.L., Hayes D.L., Ellestad M., Trupp R.J., Underwood J., Pickering F., Truex C., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845-1853.
5. Moss A.J., Hall W.J., Cannom D.S., Klein H., Brown M.W., Daubert J.P., Estes N.A., Foster E., Greenberg H., Higgins S.L., Pfeffer M.A., Solomon S.D., Wilber D., Zareba W, MADIT-CRT Trial Investigators Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009, 361:1329-1338.
6. Hiratsuji T., Adachi H., Isobe N., Tada H., Toyama T., Naito S., Hoshizaki H., Oshima S., Taniguchi K. Does cardiac resynchronization therapy improve nitric oxide concentration in exhaled gas?. J Cardiol 2004, 43:11-15.
7. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111-1115.
8. Widlansky M.E., Gokce N., Keaney J.F., Vita J.A. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003, 42:1149-1160.
9. Yeboah J., Crouse J.R., Hsu F.C., Burke G.L., Herrington D.M. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007, 115:2390-2397.
10. Hijmering M.L., Stroes E.S., Pasterkamp G., Sierevogel M., Banga J.D., Rabelink T.J. Variability of flow mediated dilation: consequences for clinical application. Atherosclerosis 2001, 157:369-373.
11. Kuvin J.T., Patel A.R., Sliney K.A., Pandian N.G., Sheffy J., Schnall R.P., Karas R.H., Udelson J.E. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003, 146:168-174.
12. Hamburg N.M., Keyes M.J., Larson M.G., Vasan R.S., Schnabel R., Pryde M.M., Mitchell G.F., Sheffy J., Vita J.A., Benjamin E.J. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008, 117:2467-2474.
13. Bonetti P.O., Barsness G.W., Keelan P.C., Schnell T.I., Pumper G.M., Kuvin J.T., Schnall R.P., Holmes D.R., Higano S.T., Lerman A. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003, 41:1761-1768.
14. Smith C.J., Sun D., Hoegler C., Roth B.S., Zhang X., Zhao G., Xu X.B., Kobari Y., Pritchard K., Sessa W.C., Hintze T.H. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 1996, 78:58-64.
15. Katz S.D., Khan T., Zeballos G.A., Mathew L., Potharlanka P., Knecht M., Whelan J. Decreased activity of the l-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation 1999, 99:2113-2117.
16. Bauersachs J., Bouloumie A., Fraccarollo D., Hu K., Busse R., Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 1999, 100:292-298.
17. Colombo P.C., Banchs J.E., Celaj S., Talreja A., Lachmann J., Malla S., DuBois N.B., Ashton A.W., Latif F., Jorde U.P., Ware J.A., LeJemtel T.H. Endothelial cell activation in patients with decompensated heart failure. Circulation 2005, 111:58-62.
18. Noris M., Morigi M., Donadelli R., Aiello S., Foppolo M., Todeschini M., Orisio S., Remuzzi G., Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995, 76:536-543.
19. Kihara T., Biro S., Imamura M., Yoshifuku S., Takasaki K., Ikeda Y., Otuji Y., Minagoe S., Toyama Y., Tei C. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. J Am Coll Cardiol 2002, 39:754-759.
20. Poelzl G., Frick M., Lackner B., Huegel H., Alber H.F., Mair J., Herold M., Schwarzacher S.P., Pachinger O., Weidinger F. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function. Int J Cardiol 2006, 108:48-54.